Grubb P.W. Patents for chemicals, pharmaceuticals and biotechnology: fundamentals of global law, practice and strategy (Oxford, 2010). - ОГЛАВЛЕНИЕ / CONTENTS
Навигация

Архив выставки новых поступлений | Отечественные поступления | Иностранные поступления | Сиглы
ОбложкаGrubb P.W. Patents for chemicals, pharmaceuticals and biotechnology: fundamentals of global law, practice and strategy / P.W.Grubb, P.L.Thomsen. - 5th ed. - Oxford: Oxford University Press, 2010. - xlv, 537 p.: ill. - Incl. bibl. ref. - Ind.: p.517-537. - ISBN 978-0-19-957523-7
 

Оглавление / Contents
 
List of Figures and Tables ................................... xiii
Table of Cases ................................................. xv
Table of Legislation ....................................... xxxiii
List of Abbreviations ......................................... xli

PART I:  INTRODUCTION AND BACKGROUND TO THE MODERN PATENT
         SYSTEM

1  The Nature and Origins of Patent Rights ...................... 3
   What is a Patent? ............................................ 3
   Early History in England ..................................... 8
   Early History in Continental Europe ......................... 10
   Early History in North America .............................. 12
   Consideration for the Grant of a Patent ..................... 14
2  Historical Developments ..................................... 15
   The UK 1800-2009 ............................................ 16
   The USA 1790-2009 ........................................... 20
   Other Industrialized Countries .............................. 24
   Developing Countries ........................................ 26
   International Developments .................................. 28
   Outlook ..................................................... 36
3  Harmonization of Patent Law ................................. 38
   Introduction ................................................ 39
   The TRIPs Agreement ......................................... 39
   TRIPs Implementation: Changes to Patent Laws ................ 42
   Further Initiatives on Harmonization ........................ 50
   The Convention on Biological Diversity ...................... 52
   Opposition to TRIPs ......................................... 54
   Summary ..................................................... 57

PART II: PATENT LAW AND PROCEDURE

4  What can be Patented ........................................ 61
   Introduction ................................................ 61
   The Requirements of the European Patent Convention and
   European National Laws ...................................... 62
   The Requirements of US Law .................................. 72
   Grace Periods ............................................... 76
   Special Categories of Invention ............................. 77
5  Filing a Patent Application ................................. 81
   Should an Application be Filed? ............................. 81
   When to File ................................................ 82
   Where to File ............................................... 86
   The Foreign Filing Decision ................................. 90
   Non-Convention Filings ...................................... 94
   European Patent Applications ................................ 94
   International Applications .................................. 96
   Registrations and Patents of Importation .................... 97
   Petty Patents ............................................... 98
6  Obtaining a Granted Patent: Patent Cooperation Treaty
   Procedure .................................................. 100
   Patent Cooperation Treaty Procedure ........................ 100

Chapter I:  Filing an International Application ............... 101

Chapter II: The International Preliminary Report on
            Patentability ..................................... 108

7  Obtaining a Granted Patent: European Patent Office
   Procedure .................................................. 115
   Procedure in the European Patent Office .................... 115
   Appeals in the European Patent Office ...................... 130
8  Obtaining a Granted Patent: National Procedures ............ 135
   Types of Examination ....................................... 135
   Deferred Examination ....................................... 138
   Oppositions ................................................ 141
   Procedure in the UK ........................................ 143
   Procedure in the USA ....................................... 150
9  Maintaining a Patent in Force and Extending the Patent
   Term ....................................................... 163
   Patent Term ................................................ 163
   Renewal Fees ............................................... 164
   Extension of Term .......................................... 168
   Extensions to Compensate for Regulatory Delays ............. 170
   Working Requirements ....................................... 178
   Licences of Right .......................................... 179
10 Enforcing Patent Rights .................................... 181
   What Constitutes Infringement .............................. 181
   Infringement in the UK ..................................... 182
   Infringement in the USA .................................... 188
   Procedure in the UK ........................................ 193
   Procedure in the USA ....................................... 199
   Procedure in Continental Europe ............................ 203
   Procedure in Asia .......................................... 206
11 Invalidity and Amendment of Granted Patents ................ 208
   Introduction ............................................... 208
   Grounds of Invalidity in the UK ............................ 209
   Revocation Proceedings ..................................... 210
   Amendment of British Patents ............................... 213
   Invalidity and Amendment in the USA ........................ 215
   Invalidity and Amendment in the European Patent Office ..... 221

PART III: PATENTABILITY OF INVENTIONS IN SPECIFIC TECHNICAL FIELDS

12 Chemical Inventions ........................................ 229
   Novel Compounds ............................................ 229
   Selection Inventions ....................................... 232
   Disclaimers ................................................ 238
   Compounds of Unknown Structure ............................. 240
   Polymeric Compounds ........................................ 241
   New Salt Forms ............................................. 243
   New Physical Forms ......................................... 243
   New Synthetic Processes .................................... 244
   Analogy Processes .......................................... 246
   New Compositions and Mixtures .............................. 246
   New Uses and New Application Processes ..................... 247
13 Pharmaceutical Inventions .................................. 250
   New Chemical Entities ...................................... 250
   Pharmaceutical Compositions ................................ 257
   First Pharmaceutical Use ................................... 258
   Second Pharmaceutical Use .................................. 259
   Scope of Supplementary Protection Certificates ............. 265
   Other Exclusivity Periods .................................. 267
   Integrated View on Exclusivity ............................. 273
14 Biotechnological Inventions ................................ 274
   What is Biotechnology? ..................................... 274
   Patents and Biotechnology .................................. 275
   Microbiological Inventions ................................. 276
   Recombinant DNA Technology ................................. 279
   Monoclonal Antibody Technology ............................. 291
   More Recent Technologies ................................... 294
   Biosimilars and Follow-on Biologics ........................ 298
15 Patenting of Genes, Plants, and Animals .................... 301
   Patents and Life ........................................... 301
   Human Genes ................................................ 302
   Transgenic Animals ......................................... 304
   Transgenic Plants .......................................... 306
   Patenting of Animals, Plants, and Human Cells .............. 307
   Morality Issues ............................................ 315
   Patents for Life: From Bacteria to the OncoMouse® .......... 317
   Why are Patents Being Targeted? ............................ 319
16 Software-Related and Business Method Inventions ............ 321
   Relevance of Software and Business Method Inventions
   to Chemistry and Biotechnology ............................. 321
   Patenting of Software-Related Inventions in the European
   Patent Office .............................................. 322
   Patenting of Software-Related Inventions in the UK ......... 327
   Patenting of Software-Related Inventions in the USA ........ 329
   Business Method Patents .................................... 330

PART IV:  PATENTING IN PRACTICE

17 The Patent Practitioner and his Functions .................. 339
   Introduction ............................................... 339
   The British Patent Profession .............................. 340
   The Patent Profession in the USA ........................... 343
   The Patent Profession in Other Countries ................... 345
   European Patent Attorneys .................................. 346
   Patent Attorneys in Private Practice ....................... 349
   Industrial Practice ........................................ 350
   The Job of the Patent Practitioner ......................... 352
18 Drafting the Patent Specification .......................... 356
   Drafting the Scope ......................................... 356
   The Structure of the Patent Specification .................. 358
   Priority and Foreign Filing Texts .......................... 360
   Background of the Invention and Prior Art .................. 360
   US Sufficiency Requirements ................................ 362
   Sufficiency Requirements in the UK and the European
   Patent Office .............................................. 366
   Sufficiency Requirements in Other Countries ................ 368
   Special Requirements for Biotech Inventions ................ 368
   Length of Text ............................................. 370
19 Drafting the Claims ........................................ 372
   The Purpose and Nature of Patent Claims .................... 372
   Form of Claims ............................................. 376
   The Scope of the Claims .................................... 381
20 Prosecution of the Patent Application to Grant ............. 385
   Introduction ............................................... 385
   Lack of Unity .............................................. 385
   Lack of Novelty ............................................ 389
   Lack of Inventive Step ..................................... 394
   Interviews with the Examiner ............................... 399

PART V: COMMERCIAL EXPLOITATION OF PATENTS

21 Inventorship, Ownership, and Compensation .................. 403
   Inventorship in the UK ..................................... 403
   Inventorship in the European Patent Office ................. 406
   Inventorship in the USA .................................... 407
   Ownership .................................................. 409
   Compensation for Employee-Inventors ........................ 414
   The Right to Apply for a Patent and to be Granted a
   Patent ..................................................... 418
   Co-Ownership ............................................... 419
   Disputes as to Ownership ................................... 419
   Recordal and Transfer of Ownership ......................... 422
22 Commercial Exploitation of Patents ......................... 423
   Patents to Exclude the Competition: The Pharmaceutical
   Industry ................................................... 423
   Patents for Survival: The Biotechnology Industry ........... 431
   Patents as a Source of Royalty Income: Universities ........ 434
   Patents as Lottery Tickets: Individual Inventors ........... 437
   Patents as Bargaining Chips: The Electronics Industry ...... 438
   Patents as Tools of Extortion: Patent Trolls ............... 439
23 How to Catch the Infringer—and How not to be Caught ........ 441
   From the Viewpoint of the Patentee ......................... 441
   From the Viewpoint of the Potential Infringer .............. 458
24 Patent Aspects of Licensing ................................ 463
   Patent Conflict Licences ................................... 463
   Technology Transfer Licences ............................... 464
   The In-licensing Process ................................... 466
   Out-licensing: Patent Strategy for the Licensor ............ 470
   Research Collaboration Agreements .......................... 472
   Contract Research Agreements ............................... 475
   Funding Agreements ......................................... 475
   Compound Purchase Agreements ............................... 475
   Licence Contracts .......................................... 476
25 Patents and Competition Law ................................ 480
   Charges Against the Patent System .......................... 481
   Competition Law: The UK .................................... 481
   Competition Law: The European Union ........................ 482
   Patent Licence Agreements in the European Union ............ 488
   Competition Law: The USA ................................... 497

Glossary ...................................................... 505

Index ......................................................... 517


Архив выставки новых поступлений | Отечественные поступления | Иностранные поступления | Сиглы
 

[О библиотеке | Академгородок | Новости | Выставки | Ресурсы | Библиография | Партнеры | ИнфоЛоция | Поиск]
  © 1997–2024 Отделение ГПНТБ СО РАН  

Документ изменен: Wed Feb 27 14:22:30 2019. Размер: 17,527 bytes.
Посещение N 1724 c 23.08.2011